Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
A patent is an exclusive right awarded by the intellectual property (IP) authority of a state to an inventor or his assignee for a limited period of time in lieu of disclosure of an invention for the benefit of mankind. In recent times, it has become a practice by a …
A federal advisory panel voted narrowly on Tuesday to recommend a ban on Percocet and Vicodin, two of the most popular prescription painkillers in the world, because of their effects on the liver. The two drugs combine a narcotic with acetaminophen, the ingredient found in popular over-the-counter products like Tylenol …
Used phony journals to push Vioxx pharma giant Merck has been accused of using unscrupulous methods, including publication of fake journals, to promote its anti-arthritis drug Vioxx. The evidence against Merck was presented before an Australian court in May after it began hearing a four-year-old lawsuit. Merck paid a well-known …
Khomba Singh NEW DELHI IN a move aimed to ensure supply of low-cost HIV drugs globally, UNITAID, an international facility for purchase of drugs against HIV/AIDS, malaria and tuberculosis (TB), held discussions with Indian generic drug makers on Tuesday to develop the world
...But Indian Govt Still To Place Orders THE first vaccine against the swine flu is likely to be globally available by August. Australia-based biopharmaceutical company CSL is all set to become the first company in the world to develop and manufacture a vaccine against the H1N1 virus and expects it …
A MAJOR new study identifying a broad range of potential benefits of incremental pharmaceutical innovation for India will be released at the US-India Business Council
Bangalore: In a significant move aimed at making clinical trials on human beings more ethical and transparent, the Drugs Controller of India has ruled for the first time that all clinical trials taking place across the country in all areas of health
Mashelkar report says modified organisms are intellectual property THE expert group on patent law headed by R A Mashelkar has recommended that microbes like bacteria, fungi and virus should be patented if they have been modified. The committee has also said India cannot limit its patents to new chemical substances …
With 12 out of about 130 drug samples in 2007-08 failing laboratory tests, the quality of drugs for humans and livestock animals supplied in Bhutan is under a cloud of questions. Bhutan
Responding to the show-cause notices issued by the Sindh Environment Protection Agency (Sepa), a number of industrialists on Wednesday clarified their position with regard to their failure to meet the safe environmental standards, a source in the agency said. According to the source, owners and executives holding responsible positions in …
India is an increasingly influential player in the global pharmaceutical market. Key parts of the drug regulatory system are controlled by the states, each of which applies its own standards for enforcement, not always consistent with others. A pilot study was conducted in two major cities in India, Delhi and …
With demand for the antidote to H1N1 infection peaking across the world, the select Indian pharmaceutical companies are ramping up production of Tamiflu or its generic version. At least one such company, Hetero Drugs, is already in the process of supplying 1 million capsules to the Government of India and …
Companies are starting preliminary work on a vaccine for the H1N1 flu, or swine flu, and should begin clinical trials soon, but the new vaccine will not be ready for widespread use until October, United States health officials said. Dr. Anne Schuchat of the federal Centers for Disease Control and …
Leading pharmaceutical company Pfizer Inc has entered into a partnership with Ahmedabad-based Claris Lifesciences Ltd to commercialise sterile injectible drugs that are off-patent and have lost exclusivity in the United States, Canada, Australia, New Zealand and Europe. These drugs cover a range of therapeutic areas, including anti-infectives, antibiotics and other …
